Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00520-011-1289-3.pdf
Reference33 articles.
1. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867
2. Balkwill F, Mantovani A (2010) Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87:401–406
3. Anderson GM, Nakada MT, DeWitte M (2004) Tumor necrosis factor-[alpha] in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4:314–320
4. Michalaki KS, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-a correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 91:1227
5. Scambia UT, Benedetti Panici P, Foti' E, Martucci R, Gadducci A, Perillo A, Facchini V (1995) Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 71:354–356
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined Neutrophil-to-Lymphocyte Ratio Score Is Associated With Chemotherapeutic Response and Predicts Prognosis in Patients With Advanced Pancreatic Cancer;Anticancer Research;2024-03-27
2. Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy;Current Molecular Pharmacology;2023-06
3. Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer;Clinical Medicine Insights: Oncology;2022-01
4. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study;Journal of Cachexia, Sarcopenia and Muscle;2021-08-02
5. Comparing the protective effects of resveratrol, curcumin and sulforaphane against LPS/IFN-γ-mediated inflammation in doxorubicin-treated macrophages;Scientific Reports;2021-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3